News

April 13, 2011 – The American College of Cardiology Foundation (ACCF), American Heart Association (AHA) and the Heart Failure Society of America (HFSA) have released results of a recent survey to...

A transcatheter ventricular assist device performed better than intra-aortic balloon pumps (IABP), with a 21 percent reduction in major adverse events at 90 days.

March 28, 2011 – The Therapeutic Goods Administration (TGA) of Australia has approved the HeartWare Ventricular Assist System for listing on the Australian Register of Therapeutic Goods (ARTG).

March 11, 2011 – Texas Children's has become the world's first pediatric hospital to complete the first phase of certification to implant the SynCardia temporary Total Artificial Heart. The...

February 17, 2011 – On Jan. 15, after 864 days of life with an artificial heart, Charles Okeke received a dual heart and kidney transplant at the Mayo Clinic Hospital in Phoenix. Okeke had been...

January 27, 2011 – The U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) Supplement allowing more patients to participate in the ADVANCE trial. The...

January 26, 2011 - The University of Michigan Cardiovascular Center and the University of Pittsburgh have been awarded $13.3 million to explore the potential benefits of heart devices for the...

January 13, 2011 – HeartWare International has submitted a Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration for its ventricular assist system. The system acts as a...

January 3, 2011 – Arrow International, a division of Teleflex Medical, issued a class I recall, advising customers to immediately discontinue use of its Ultra 8 French intra-aortic balloon pump (...

December 7, 2010 – A study comparing a transcatheter ventricular assist device (VAD) to intra-aortic balloon pumps (IABP) has been completed after interim analysis determined the primary endpoint...

December 6, 2010 – The U.S. Food and Drug Administration (FDA) has given conditional approval for a trial that will investigate the role of a device in reducing infarct size in patients with ST-...

November 17, 2010 – Data from the ADVANCE bridge-to-heart-transplant study showed that 92 percent of patients were either alive on the implanted device, had a heart transplant or explanted for...

November 15, 2010 - An experimental pump implanted in patients waiting for a heart transplant works as well as approved devices, according to trial results presented at the American Heart...

October 18, 2010 - A 54-year-old Italian man has become the first patient to surpass 1,000 days of support with an artificial heart while waiting for a matching donor heart. The patient was...

October 18, 2010 – Toronto General Hospital is the first Canadian medical center to implant a left-ventricular assist system (LVAS) as part of a study for patients awaiting a heart transplant. The...

October 1, 2010 – The most recent clinical data from USpella, a U.S. multicenter, observational registry of patients who received percutaneous cardiac support from the Impella 2.5 device, was...

September 30, 2010 – A specialized partner program was recently launched to enable select top healthcare institutions to provide advanced training in hemodynamic support and complex patient...

September 21, 2010 – Ventricular assist devices (VADs) can restore normal hemodynamics and support recovery of native cardiac function after acute myocardial infarction (AMI), according to a study...

September 20, 2010 – Transcatheter ventricular assist device (VAD) company Abiomed will highlight its devices at several events during the 2010 Transcatheter Cardiovascular Therapeutics (TCT)...

September 10, 2010 – The first patient was successfully supported for six days by the Impella Right Peripheral (RP) ventricular assist device (VAD) at the Providence Heart and Lung Institute at St...